PT - JOURNAL ARTICLE AU - Emanuele Barca AU - Yuelin Long AU - Victoria Cooley AU - Robert Schoenaker AU - Valentina Emmanuele AU - Salvatore DiMauro AU - Bruce H. Cohen AU - Amel Karaa AU - Georgirene D. Vladutiu AU - Richard Haas AU - Johan L.K. Van Hove AU - Fernando Scaglia AU - Sumit Parikh AU - Jirair K. Bedoyan AU - Susanne D. DeBrosse AU - Ralitza H. Gavrilova AU - Russell P. Saneto AU - Gregory M. Enns AU - Peter W. Stacpoole AU - Jaya Ganesh AU - Austin Larson AU - Zarazuela Zolkipli-Cunningham AU - Marni J. Falk AU - Amy C. Goldstein AU - Mark Tarnopolsky AU - Andrea Gropman AU - Kathryn Camp AU - Danuta Krotoski AU - Kristin Engelstad AU - Xiomara Q. Rosales AU - Joshua Kriger AU - Johnston Grier AU - Richard Buchsbaum AU - John L.P. Thompson AU - Michio Hirano TI - Mitochondrial diseases in North America AID - 10.1212/NXG.0000000000000402 DP - 2020 Apr 01 TA - Neurology Genetics PG - e402 VI - 6 IP - 2 4099 - http://ng.neurology.org/content/6/2/e402.short 4100 - http://ng.neurology.org/content/6/2/e402.full SO - Neurol Genet2020 Apr 01; 6 AB - Objective To describe clinical, biochemical, and genetic features of participants with mitochondrial diseases (MtDs) enrolled in the North American Mitochondrial Disease Consortium (NAMDC) Registry.Methods This cross-sectional, multicenter, retrospective database analysis evaluates the phenotypic and molecular characteristics of participants enrolled in the NAMDC Registry from September 2011 to December 2018. The NAMDC is a network of 17 centers with expertise in MtDs and includes both adult and pediatric specialists.Results One thousand four hundred ten of 1,553 participants had sufficient clinical data for analysis. For this study, we included only participants with molecular genetic diagnoses (n = 666). Age at onset ranged from infancy to adulthood. The most common diagnosis was multisystemic disorder (113 participants), and only a minority of participants were diagnosed with a classical mitochondrial syndrome. The most frequent classical syndromes were Leigh syndrome (97 individuals) and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (71 individuals). Pathogenic variants in the mitochondrial DNA were more frequently observed (414 participants) than pathogenic nuclear gene variants (252 participants). Pathogenic variants in 65 nuclear genes were identified, with POLG1 and PDHA1 being the most commonly affected. Pathogenic variants in 38 genes were reported only in single participants.Conclusions The NAMDC Registry data confirm the high variability of clinical, biochemical, and genetic features of participants with MtDs. This study serves as an important resource for future enhancement of MtD research and clinical care by providing the first comprehensive description of participant with MtD in North America.CoQ10=coenzyme Q10; COX=cytochrome c oxidase; cPEO=chronic progressive external ophthalmoplegia; IRB=institutional review board; LS=Leigh syndrome; LHON=Leber hereditary optic neuropathy; MELAS=mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes; MERRF=myoclonus epilepsy with ragged red fibers; MtD=mitochondrial disease; mtDNA=mitochondrial DNA; NAMDC=North American Mitochondrial Disease Consortium; nDNA=nuclear DNA; OxPhos=oxidative phosphorylation; PDC=pyruvate dehydrogenase complex; SLE=stroke-like episode; TP=thymidine phosphorylase